跳至主要内容
临床试验/NCT00022165
NCT00022165
已完成
不适用

Prevention Of Cancer By Intervention With Selenium

University of Surrey3 个研究点 分布在 1 个国家目标入组 501 人1999年10月

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Unspecified Adult Solid Tumor, Protocol Specific
发起方
University of Surrey
入组人数
501
试验地点
3
状态
已完成
最后更新
10年前

概览

简要总结

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. Selenium may be effective in preventing cancer. It is not yet known which dose of selenium may be most effective in preventing cancer.

PURPOSE: Randomized pilot study to determine the effectiveness of selenium in preventing cancer in healthy people.

详细描述

OBJECTIVES: I. Determine whether daily supplementation with selenium significantly reduces total cancer incidence and site-specific cancer incidence in the general population. II. Determine whether this regimen has a beneficial effect on mood. OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Participants are stratified according to age (60-64 vs 65-69 vs 70-74). Participants are randomized to one of four arms. Arm I: Participants receive oral placebo once daily. Arm II: Participants receive low-dose oral selenium once daily. Arm III: Participants receive moderate-dose oral selenium once daily. Arm IV: Participants receive high-dose oral selenium once daily. Treatment in all arms continues for up to 2 years in the absence of unacceptable side effects or diagnosis of cancer. PROJECTED ACCRUAL: A total of 510 patients (170 per stratum) will be accrued for this study within 9-12 months.

注册库
clinicaltrials.gov
开始日期
1999年10月
结束日期
2002年1月
最后更新
10年前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

未指定

研究点 (3)

Loading locations...

相似试验